Skip to main content

Table 1 Characteristics of Patients in the Primary and Validation Cohorts after randomization

From: A novel risk-predicted nomogram for sepsis associated-acute kidney injury among critically ill patients

Variable

Primary Cohort

Validation Cohort

Age (years)

69 (56,81)

68 ( 55,81)

Male, n (%)

1112 (55.27)

470 ( 54.71)

BMI, n (%)

 Normal

624 ( 31.01)

254 (29.57 )

 Overweight

396 ( 19.68)

203 ( 23.63 )

 Obesity

923 (45.87)

366 (42.61)

 Underweight

69 (3.43 )

36 ( 4.19 )

 LOS in ICU (days)

3.7 ( 1.9, 8.9 )

2.9 ( 1.9, 9.9 )

 SIRS

3 ( 3, 4)

3 ( 3, 4)

Anemia, n (%)

 Normal

491 ( 24.40 )

176 ( 20.49 )

 Mild anemia

1090 ( 54.17 )

460 ( 53.55 )

 Moderate anemia

428 ( 21.27 )

222 (25.84 )

 Severe anemia

3 ( 0.15 )

1 ( 0.12 )

 Glucose ( mmol/L)

7.0 ( 4.3, 11.9)

7.0 ( 4.2, 11.4 )

 Basline SCr ( umol/L)

124 ( 80,194)

124 ( 80,203)

Albumin, n (%)

 < 30 g/L

932 ( 46.32 )

420 ( 48.89 )

 >= 30 g/L

1080 ( 53.68 )

439 ( 51.11 )

Chronic medical conditions, n (%)

 COPD

44 ( 2.19 )

15 ( 1.75 )

 CKD

338 ( 16.8 )

165 ( 19.21 )

 Chronic liver disease

105 ( 5.22 )

59 ( 6.87 )

 Diabetes

633 ( 31.46 )

254 ( 29.57 )

 Coronary disease

334 ( 16.60 )

121 ( 14.09 )

 Malignant

439 ( 21.82 )

176 ( 20.49 )

 Hypertension

798 ( 39.66 )

311 ( 36.20 )

Comorbidity, n (%)

 Acute pancreatitis

115 ( 5.72 )

39 ( 4.54 )

 Lactic acidosis

469 ( 23.31 )

209 ( 24.33 )

 Heart failure

631 ( 31.36 )

253 ( 29.45 )

 Hypotension

110 ( 5.47 )

54 ( 6.29 )

Medication, n (%)

 Vasoactive drugs

891 ( 44.28 )

388 ( 45.17 )

 Diuretic

760 ( 37.77 )

301 ( 35.04 )

 Aminoglycosides

1516 ( 75.35 )

645 ( 75.09 )

 Lactated Ring

118 ( 5.86 )

52 ( 6.05 )

 Human albumin

222 ( 11.03 )

91 ( 10.59 )

  1. BMI body mass index; SCr Serum creatinine; LOS in ICU length of stay in intensive care unit; SIRS Systemic inflammatory score; COPD chronic obstructive pulmonary disease; CKD chronic kidney disease